Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Losartan Interactions with 2-Hydroxypropyl-β-CD.
Palli V, Leonis G, Zoupanou N, Georgiou N, Chountoulesi M, Naziris N, Tzeli D, Demetzos C, Valsami G, Marousis KD, Spyroulias GA, Mavromoustakos T. Palli V, et al. Among authors: valsami g. Molecules. 2022 Apr 8;27(8):2421. doi: 10.3390/molecules27082421. Molecules. 2022. PMID: 35458617 Free PMC article.
Investigation of the interactions of silibinin with 2-hydroxypropyl-β-cyclodextrin through biophysical techniques and computational methods.
Kellici TF, Ntountaniotis D, Leonis G, Chatziathanasiadou M, Chatzikonstantinou AV, Becker-Baldus J, Glaubitz C, Tzakos AG, Viras K, Chatzigeorgiou P, Tzimas S, Kefala E, Valsami G, Archontaki H, Papadopoulos MG, Mavromoustakos T. Kellici TF, et al. Among authors: valsami g. Mol Pharm. 2015 Mar 2;12(3):954-65. doi: 10.1021/mp5008053. Epub 2015 Feb 19. Mol Pharm. 2015. PMID: 25665128
Exploring the interactions of irbesartan and irbesartan-2-hydroxypropyl-β-cyclodextrin complex with model membranes.
Liossi ΑS, Ntountaniotis D, Kellici TF, Chatziathanasiadou MV, Megariotis G, Mania M, Becker-Baldus J, Kriechbaum M, Krajnc A, Christodoulou E, Glaubitz C, Rappolt M, Amenitsch H, Mali G, Theodorou DN, Valsami G, Pitsikalis M, Iatrou H, Tzakos AG, Mavromoustakos T. Liossi ΑS, et al. Among authors: valsami g. Biochim Biophys Acta Biomembr. 2017 Jun;1859(6):1089-1098. doi: 10.1016/j.bbamem.2017.03.003. Epub 2017 Mar 6. Biochim Biophys Acta Biomembr. 2017. PMID: 28274845 Free article.
Exploring the oxidation and iron binding profile of a cyclodextrin encapsulated quercetin complex unveiled a controlled complex dissociation through a chemical stimulus.
Diamantis DA, Ramesova S, Chatzigiannis CM, Degano I, Gerogianni PS, Karadima KE, Perikleous S, Rekkas D, Gerothanassis IP, Galaris D, Mavromoustakos T, Valsami G, Sokolova R, Tzakos AG. Diamantis DA, et al. Among authors: valsami g. Biochim Biophys Acta Gen Subj. 2018 Sep;1862(9):1913-1924. doi: 10.1016/j.bbagen.2018.06.006. Epub 2018 Jun 8. Biochim Biophys Acta Gen Subj. 2018. PMID: 29886278
Host-Guest Interactions between Candesartan and Its Prodrug Candesartan Cilexetil in Complex with 2-Hydroxypropyl-β-cyclodextrin: On the Biological Potency for Angiotensin II Antagonism.
Ntountaniotis D, Andreadelis I, Kellici TF, Karageorgos V, Leonis G, Christodoulou E, Kiriakidi S, Becker-Baldus J, Stylos EK, Chatziathanasiadou MV, Chatzigiannis CM, Damalas DE, Aksoydan B, Javornik U, Valsami G, Glaubitz C, Durdagi S, Thomaidis NS, Kolocouris A, Plavec J, Tzakos AG, Liapakis G, Mavromoustakos T. Ntountaniotis D, et al. Among authors: valsami g. Mol Pharm. 2019 Mar 4;16(3):1255-1271. doi: 10.1021/acs.molpharmaceut.8b01212. Epub 2019 Feb 13. Mol Pharm. 2019. PMID: 30681344
Charting the structural and thermodynamic determinants in phenolic acid natural product - cyclodextrin encapsulations.
Andreadelis I, Chatziathanasiadou ΜV, Ntountaniotis D, Valsami G, Papaemmanouil C, Christodoulou E, Mitropoulou G, Kourkoutas Y, Tzakos AG, Mavromoustakos T. Andreadelis I, et al. Among authors: valsami g. J Biomol Struct Dyn. 2021 Apr;39(7):2642-2658. doi: 10.1080/07391102.2020.1751716. Epub 2020 Apr 16. J Biomol Struct Dyn. 2021. PMID: 32249691
Antihypertensive activity and molecular interactions of irbesartan in complex with 2-hydroxypropyl-β-cyclodextrin.
Leonis G, Christodoulou E, Ntountaniotis D, Chatziathanasiadou MV, Mavromoustakos T, Naziris N, Chountoulesi M, Demetzos C, Valsami G, Damalas DE, Tzakos AG, Thomaidis NS, Karageorgos V, Liapakis G. Leonis G, et al. Among authors: valsami g. Chem Biol Drug Des. 2020 Jul;96(1):668-683. doi: 10.1111/cbdd.13664. Chem Biol Drug Des. 2020. PMID: 32691965
Preparation and Biophysical Characterization of Quercetin Inclusion Complexes with β-Cyclodextrin Derivatives to be Formulated as Possible Nose-to-Brain Quercetin Delivery Systems.
Manta K, Papakyriakopoulou P, Chountoulesi M, Diamantis DA, Spaneas D, Vakali V, Naziris N, Chatziathanasiadou MV, Andreadelis I, Moschovou K, Athanasiadou I, Dallas P, Rekkas DM, Demetzos C, Colombo G, Banella S, Javornik U, Plavec J, Mavromoustakos T, Tzakos AG, Valsami G. Manta K, et al. Among authors: valsami g. Mol Pharm. 2020 Nov 2;17(11):4241-4255. doi: 10.1021/acs.molpharmaceut.0c00672. Epub 2020 Oct 19. Mol Pharm. 2020. PMID: 32986435
101 results